Infection with SARS-CoV-2 following Second Dose Pfizer-BioNTech mRNA COVID-19 Vaccine BNT162b2 in Danish Adolescents Aged 12–18 Years: A Real-World Nationwide Danish Cohort Study

Infection with SARS-CoV-2 following Second Dose Pfizer-BioNTech mRNA COVID-19 Vaccine BNT162b2 in Danish Adolescents Aged 12–18 Years: A Real-World Nationwide Danish Cohort Study

In this real-world cohort study based on Danish nationwide registers, the cumulated proportion, relative risk (RR) of SARS-CoV-2 breakthrough infections, and vaccine effectiveness (VE) were investigated in adolescents aged 12–18 years following vaccination with the BNT162b2 vaccine compared to unvac...

Full description

Bibliographic Details
Main Authors: Nina Marie Birk, Anne Vinggaard Christensen, Ulrikka Nygaard, Henning Bundgaard, Susanne Dam Nielsen, Selina Kikkenborg Berg, Helle Wallach-Kildemoes
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Viruses
Subjects:
COVID-19
BNT162b2 vaccine
vaccine effectiveness
adolescents
real-world data
Online Access:https://www.mdpi.com/1999-4915/16/1/56

Internet

https://www.mdpi.com/1999-4915/16/1/56

Similar Items